Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor.
Barnes
R B
RB
Department of Obstetrics and Gynecology, University of Chicago, Pritzker School of Medicine, Illinois 60637, USA.
Ehrmann
D A
DA
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006628:Hirsutism / Q000209:etiology; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D013739:Testosterone / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D003692:Delayed-Action Preparations; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D016729:Leuprolide